Pretreatment Posttreatment Difference Wilcoxon
Mean SD Mean SD Mean SD P
1 SNA (º) 80.27 3.73 79.37 3.54 -0.9 1.43 *
2 SNB (º) 75.53 4.2 76.17 4.38 0.63 1.23  
3 ANB (º) 4.80 1.77 3.47 1.9 -1.33 1.08 **
4 SN/PP (º) 9.83 3.36 10.33 2.7 0.5 2.6  
5 SN/MP (º) 32.73 5.65 32.4 5.69 -0.33 0.94  
6 SE (mm) 20.35 3.07 20.51 3.02 0.17 1.15  
7 SL (mm) 45.01 9.46 45.71 8.9 0.7 1.88  
8 Pg-NB (mm) 3.91 1.64 3.82 1.57 -0.09 0.8  
9 Ar-Pg (mm) 99.19 6.94 100.73 7.5 1.54 1.97 *
10 A-RL2 (mm) 63.93 4.8 63.95 5.11 0.03 1.28  
11 B-RL2 (mm) 54.91 7.76 56.32 7.42 1.41 1.54 **
12 A-RL1 (mm) 48.36 4.03 48.66 4.22 0.3 1.81  
13 ANS-Me/N-Me (%) 0.54 0.024 0.537 0.023 0 0.01  
14 Jarabak Ratio (%) 0.67 0.08 0.66 0.05 0 0.05  
15 GonialRatio(%) 0.71 0.06 0.71 0.06 0 0.01  
16 S-Ar/Ar-Go (%) 0.78 0.1 0.75 0.1 -0.03 0.06 *
17 U1/SN (º) 104.43 5.38 100.73 7.22 -3.70 3.63 **
18 IMPA (º) 98.9 7.63 104.53 7.57 5.63 3.67 **
19 L1/RL2 (º) 34.27 6.4 40.27 5.91 6 4.22 **
20 Interincisal Angle (º) 124.3 7.43 122.53 6.71 -1.77 5.61  
21 SN/OP (º) 18.43 4.87 21.4 5.42 2.97 2.61 **
22 L1/NB (mm) 5.03 1.77 6.65 1.5 1.63 1.02 **
23 U6-RL1 (mm) 62.86 5.35 62.08 5.47 -0.78 0.6 **
24 U1-RL1 (mm) 70.26 4.7 71.4 4.76 1.15 0.72 **
25 Overjet (mm) 5.84 1.67 2.11 0.8 -3.73 1.89 **
26 Overbite (mm) 4.1 0.96 2.24 0.9 -1.86 0.94 **
27 H Angle (º) 13.43 4.45 12.03 5.02 -1.4 3.85 *
28 Nasolabial Angle (º) 123.73 9.82 124.57 9.5 0.83 5.08  
29 N-A-Pg (º) 174.03 5.24 176.17 5.29 2.13 2.84 *
30 A-labialis superior (mm) 21.7 3.2 21.95 2.9 0.25 1.65  
31 E line-labialis superior (mm) -2.82 2.12 -3.23 2.01 -0.41 1.15  
32 E line-labialis inferior (mm) -1.24 2.97 -0.92 3.08 0.32 0.67  
33 Labialis superior-RL2 (mm) 81.57 7.91 81.55 7.25 -0.03 1.99  
34 Labialis inferior-RL2 (mm) 75.04 7.91 76.39 7.48 1.35 1.89 *
35 Lip strength (mm) 3.9 2.85 2.79 2.69 -1.15 1.84 *
* P< 0.05, ** P< 0.01.
Table 4: Changes and Comparisons of Pretreatment and Postreatment Values within the Treatment Group.